Synlogic to present at the 2022 national pku alliance (npkua) conference

Vancouver, wash., june 28, 2022 (globe newswire) -- synlogic, inc. (nasdaq: sybx), a clinical-stage biotechnology company developing medicines for metabolic and immunological diseases through its proprietary approach to synthetic biology, announced today it will participate at the national pku alliance's (npkua) biennial conference july 7-10, 2022 in vancouver, washington. as an event sponsor, synlogic has been invited to present during the session “what's new in pku? (emerging therapies, research, foods & beyond).” in addition, the team will share data on dietary protein intake in pku patients during a poster presentation.
SYBX Ratings Summary
SYBX Quant Ranking